Investigational advanced PCa Tx extends overall survival.
| Publicado en: | Urology Times Vol. 40; no. 5; pp. 1 - 50 |
|---|---|
| Autor principal: | |
| Formato: | Journal Article |
| Publicado: |
MJH Life Sciences
May2012
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=108184579&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 108184579 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 00939722 URO jtl: Urology Times issn: 00939722 maglogo: N pubinfo: dt: May2012 vid: 40 iid: 5 pid: 54670 pub: MJH Life Sciences place: Cranbury, New Jersey artinfo: ui: 108184579 2011537572 108184579 ppf: 1 ppct: 49 formats: fmt: @attributes: type: P tig: atl: Investigational advanced PCa Tx extends overall survival. aug: au: Goodman, Alice sug: subj: Prostatic Neoplasms Drug Therapy Survival Analysis Androgen Antagonists Prostate-Specific Antigen pubtype: Academic Journal doctype: Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|